Search results
Mark P. Clein. Co-Founder, Chief Executive Officer, Precision Medicine Group. Healthcare visionary and industry leader dedicated to supporting bio-pharmaceutical companies from early development through the commercial life cycle. Co-founder and Chief Financial Officer of several successful companies.
View Mark Clein’s profile on LinkedIn, a professional community of 1 billion members. Experience: Precision Medicine Group · Education: Columbia Business School · Location: Bethesda · 500 ...
Mark Clein is the Co-Founder and CEO of Precision Medicine Group. He has over 20 years of experience in the healthcare industry. Prior to Precision, Mr. Clein was Co-Founder, President and CFO of United BioSource Corporation (UBC), which became the leader in real-world research addressing safety, value, and comparative effectiveness for the.
May 17, 2020 · Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020. You can view his address at your convenience here. In the course of his presentation you will hear: The ways in which digital technology is transforming patient care and impacting clinical trials.
Nov 20, 2020 · Mark Clein, PMG CEO, said: “We are thrilled to have Blackstone join us for this next phase of growth. Their serious commitment to the life sciences and global scope and scale make them an ideal partner to support our vision of success and expanded capabilities for the next generation of bio-pharma innovators.”
At the Meeting on the Med 2021 Conference, CEO & Co-Founder of Precision Medicine Group Mark Clein gave an informative presentation highlighting Precision ADVANCE, the cell & gene therapy collective™, and how it aligns with our mission to help bring life-changing therapies to those that need them the most.
Co-Founder and Chief Executive Officer, Precision Medicine Group. 2y. Precision Medicine Group was founded to transform the process of bringing new drugs to market by integrating...
